SUZANNE GAZDA M.D.
  • Home
  • Meet Dr. Gazda
    • Our Practice
  • Lectures/Videos
  • BLOGS
    • Blog - Long Covid
    • Blog - NEUROLOGY TRENDS
    • Blog - MS in the NEWS
    • Blog - Scientifically Speaking
    • Blog - Guest Articles
  • Our Approach
  • Conditions we treat
    • Alzheimer’s Disease
    • Amyotrophic Lateral Sclerosis (ALS)
    • Long COVID
    • Multiple Sclerosis (MS)
    • PANS | PANDAS
    • Parkinson’s disease
  • Treatment Protocols
  • Patient Stories
  • FAQ
  • Policies & Rates
  • Helpful LInks
  • Medical Resources
  • Journal Articles
  • Product Recommendations
  • Become a Patient
  • NEWS
  • Contact

Neurology
​Trends

Update: even more results for IVIG in treating small fiber neuropathy.

5/6/2021

0 Comments

 
In our blog published just last month, we looked at some of the research utilizing intravenous immunoglobulin (IVIG) for small fiber neuropathy (SFN), which occurs when damage to the peripheral nerves predominantly or entirely affects the small myelinated (Aδ) fibers or unmyelinated C fibers. ​
Picture
While not necessarily a well-known disorder, SFN does affect roughly four million people globally and can result from diabetes, vitamin B12 deficiency and autoimmune diseases.
 
A recent article featuring Anne Louise Oaklander, MD, PhD in Neurology Reviews takes a closer look at this neurological condition, its clinical presentations and the difficulties in diagnosing what may seem to be a relatively obscure disorder. But SFN is thought to be under-identified as many patients may not consult a neurologist about a wide range of symptoms from pain and itching to fatigue, gastrointestinal issues and more. Add to this the need for expanded assessment tools and physician awareness of the disease and SFN often can be overlooked as a diagnosis.1
 
Dr. Oaklander notes too that for cases originating from an autoimmune cause, another recent study reported on the success of IVIG in providing relief in a large number of research subjects. This is on top of the studies we wrote about that also supports the efficacy of immunotherapy for some SFN patients. 
 
If you would like to learn more about SFN, please be sure to read this excellent piece with Dr. Oaklander’s insights and, as always, don’t hesitate to let us know if you have questions about this or any other neurological concerns. 
 
In health,
Dr. Suzanne Gazda
 
Reference:
1
 Oaklander, A.L., Bosworth, T. Small-fiber dysimmune neuropathy emerges as a new treatable disease. Neurology Reviews, April 2021.
0 Comments

Your comment will be posted after it is approved.


Leave a Reply.

    RSS Feed

    Author

    Dr. Suzanne Gazda, Integrative Neurology

    Archives

    February 2024
    January 2024
    November 2023
    August 2023
    July 2023
    June 2023
    May 2023
    April 2023
    March 2023
    December 2022
    November 2022
    September 2022
    April 2022
    November 2021
    September 2021
    August 2021
    July 2021
    June 2021
    May 2021
    April 2021
    March 2021
    February 2021
    January 2021
    December 2020
    November 2020
    October 2020
    September 2020
    August 2020
    July 2020
    June 2020
    May 2020
    April 2020
    March 2020
    February 2020
    January 2020
    December 2019
    November 2019
    October 2019

    Categories

    All

SITE MAP

HOME
MEET DR. GAZDA
OUR PRACTICE
INTEGRATIVE MEDICINE
OUR APPROACH
CONDITIONS WE TREAT
TREATMENT PROTOCOLS
PATIENT STORIES
FAQ
POLICIES & RATES
BLOG
SCIENTIFICALLY SPEAKING
MEDICAL RESOURCES
JOURNAL ARTICLES
LINKS
BECOME A PATIENT
CONTACT
NEWS
PRODUCT RECOMMENDATIONS

Location

San Antonio, Texas

Telephone

210-692-1245
Fax
210-692-9311

Email

[email protected]
  • Home
  • Meet Dr. Gazda
    • Our Practice
  • Lectures/Videos
  • BLOGS
    • Blog - Long Covid
    • Blog - NEUROLOGY TRENDS
    • Blog - MS in the NEWS
    • Blog - Scientifically Speaking
    • Blog - Guest Articles
  • Our Approach
  • Conditions we treat
    • Alzheimer’s Disease
    • Amyotrophic Lateral Sclerosis (ALS)
    • Long COVID
    • Multiple Sclerosis (MS)
    • PANS | PANDAS
    • Parkinson’s disease
  • Treatment Protocols
  • Patient Stories
  • FAQ
  • Policies & Rates
  • Helpful LInks
  • Medical Resources
  • Journal Articles
  • Product Recommendations
  • Become a Patient
  • NEWS
  • Contact